KIF2A decreases IL-33 production and attenuates allergic asthmatic inflammation.
Zhengxia WangJingjing WuJingxian JiangQiyun MaMeijuan SongTingting XuYanan LiuZhongqi ChenYanmin BaoMao HuangMingshun ZhangNingfei JiPublished in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2022)
KIF2A suppressed mTORC1-mediated autophagy and decreased the production of epithelial-derived cytokine IL-33 in allergic airway inflammation. These data indicate that KIF2A may be a novel target in allergic asthma.